decentralized clinical trials Archives

Why CTMS Is Critical As Trial Complexities Increase

November 9, 2021

The clinical trials industry is buckling under the weight of continuously growing complexities. Developing an interconnected clinical trials ecosystem will be essential to minimizing the…

How to Sustain Clinical Trial Patient Engagement

September 7, 2021

The process of bringing a new treatment to market can be a long, arduous journey. On average, it takes ten years for a treatment to…

How eSource Optimizes The Clinical Site Experience

September 7, 2021

Trial sites are a cornerstone of clinical research but are often overloaded with a myriad of complex, manual, and time-sensitive tasks. How can sites be…

The Power of Patient-Centricity in Rare Disease Studies

September 6, 2021

Orphan drug discoveries promise unprecedented opportunities, as well as challenges. Unfortunately, research in the rare disease space presents some of the highest hurdles in medicine…

4 Reasons Decentralized Trials Are Here to Stay

July 6, 2021

Long before the global pandemic, clinical trial sponsors were consumed with accelerating their studies and improving the trial experience for key stakeholders. Decentralization emerged as…

Thank Technology: Oncology’s Golden Age Is Here

March 20, 2021

To my mom, sister, father-in-law, and late aunt, I promise this: The 2020s will be a breakthrough decade for oncology. For me, cancer isn’t some…

How Decentralized Trials Strengthen Your Participation Pool

March 16, 2021

Long before COVID-19, recruiting and retaining patients for clinical trials was a growing problem with 85% of all trials failing to recruit enough patients and…

Hesitant to Embrace Decentralized Trials Because of Regulations?

February 12, 2021

As the COVID-19 pandemic first entered the states, the U.S. Food and Drug Administration (FDA) quickly recognized that the public health emergency would disrupt the…

The Importance of Diversity in Clinical Trials

January 28, 2021

In the world of clinical trials, uniformity can be a dirty word. From blind use of placebos to dosage variation, incorporation of variables is…

The Future of Informed Consent

August 7, 2020

From eClinical data collection to telehealth to wearables and beyond, the clinical trials industry has seen a mass of technological advances over the past decade.…

Virtual, Decentralized, Hybrid: What’s the Difference?

August 3, 2020

The clinical trial landscape is ever-changing. New technology and innovation have changed the way we look at clinical trial design. While we can agree that…

5 Essential Considerations for Global Clinical Trials

May 4, 2020

Over the past 10 years, the clinical trial industry has transformed dramatically. Globalization has taken off, giving rise to Contract Resource Organization (CRO) outsourcing, decentralized…

COVID-19: The Catalyst for Change

April 23, 2020

With the onset of COVID-19, sponsors and CROs are actively looking for ways to continue non-COVID-19 trials that have been left in a standstill due…

How COVID-19 is Causing the Industry to Rethink Paper vs ePRO

April 6, 2020

As the clinical trial industry focuses on finding a “new normal” during the COVID-19 pandemic, we are focused on how Medrio can assist in your…

Patient Diversity and eClinical Vendor Selection

March 27, 2020

Regulators and many in the clinical research industry emphasize patient diversity, but how do contract research organizations (CROs) and sponsors achieve it? The US Food…

Decentralized Trials: How Modern Tech Can Transform Your Trials

February 11, 2020

Harnessing technology standard in other highly regulated industries, decentralized trials are gaining traction and becoming a more significant part of our industry. They’re not a…

Decentralized Trials: How to Get Started

January 29, 2020

Traditional clinical trial models place limitations on patients, with logistical and geographic barriers making it difficult to recruit, enroll, and retain a diverse participant pool.…

The Rise of Decentralized Trials

November 19, 2019

In our webinar, Medrio Founder, Mike Novotny, and Covance Vice President and Global Head of Hybrid and Virtual Trials, Bola Oyegunwa, shared in-depth insight into…

3 Ways Patient-Centricity Can Boost Clinical Trial ROI

October 25, 2019

There’s no question that patient recruitment, adherence, and retention are core concerns for researchers. A recent report cited there are now 40 million patients needed…

3 Reasons Why eSource Is a Must for Global Trials

July 10, 2019

What Is eSource? Source data is the initial data recording, and eSource is any source data that is recorded electronically with the goal of producing…

decentralized clinical trials

Enter a topic, term or keyword below: